Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

The number of teens and young adults taking GLP-1 drugs has increased by 594 percent—but scientists are still trying to ...

As a leading nutrition and longevity expert, I often see patients who want my advice on whether they should start taking ...

What about the side-effects? Will I regain all my weight? Dr Sarah Jarvis has the answers to your burning questions.

Weight loss medications like Wegovy and Zepbound are gaining popularity as millions turn to them for quick results and ...

Consumer Reports warns there are important considerations, especially for older adults, before starting these treatments.

Last week, the FDA officially moved Ozempic and Wegovy off its shortage list four ... were able to sell copycat versions of the drug at a much lower cost, enabling telehealth companies and medical ...

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide) and Novo Nordisk's GLP-1 agonist Wegovy ... 2% reduction in weight at 72 weeks, compared ...

The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

Altimmune's pemvidutide shows promise in treating MASH and obesity, with upcoming Phase 2b results poised to shape its market ...

The lawsuit claims the FDA's finding that there was no longer a shortage of the drugs' active ingredient semaglutide was ...